|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1183 USD | -3.03% |
|
+0.25% | -93.50% |
| 07-27 | Linkage Global Unveils Human Resonance Os Advancing Its Ai-Enabled Wellness Ecosystem | CI |
| 07-01 | Linkage Global Inc Reports Earnings Results for the Half Year Ended March 31, 2026 | CI |
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Revenues | 15.47M | 22.03M | 12.73M | 10.29M | 5.1M |
Total Revenues | 15.47M | 22.03M | 12.73M | 10.29M | 5.1M |
Cost of Goods Sold, Total | 12.93M | 18.32M | 10.87M | 6.12M | 1.4M |
Gross Profit | 2.54M | 3.7M | 1.86M | 4.17M | 3.7M |
Selling General & Admin Expenses, Total | 1.55M | 1.86M | 1.97M | 3.94M | 7.73M |
R&D Expenses | 103K | 628K | 588K | 302K | 585K |
Other Operating Expenses, Total | 1.66M | 2.49M | 2.56M | 4.24M | 8.31M |
Operating Income | 881K | 1.22M | -697K | -76.56K | -4.61M |
Interest Expense, Total | -81.88K | -79.46K | -102K | - | -2.44M |
Interest And Investment Income | - | 8.4K | 2.12K | 205K | - |
Net Interest Expenses | -81.88K | -71.05K | -100K | 205K | -2.44M |
Other Non Operating Income (Expenses) | 54.08K | 114K | 14.56K | 21.64K | 84.45K |
EBT, Excl. Unusual Items | 853K | 1.26M | -782K | 150K | -6.97M |
Gain (Loss) On Sale Of Investments | - | - | -60.05K | - | - |
Gain (Loss) On Sale Of Assets | - | 193K | 126K | - | - |
EBT, Incl. Unusual Items | 853K | 1.45M | -717K | 150K | -6.97M |
Income Tax Expense | 102K | 386K | -63.95K | 590K | 403K |
Earnings From Continuing Operations | 752K | 1.07M | -653K | -439K | -7.37M |
Net Income to Company | 752K | 1.07M | -653K | -439K | -7.37M |
Net Income - (IS) | 752K | 1.07M | -653K | -439K | -7.37M |
Net Income to Common Incl Extra Items | 752K | 1.07M | -653K | -439K | -7.37M |
Net Income to Common Excl. Extra Items | 752K | 1.07M | -653K | -439K | -7.37M |
Per Share Items | |||||
Net EPS - Basic | 0.38 | 0.53 | -0.33 | -0.21 | -1.27 |
Basic EPS - Continuing Operations | 0.38 | 0.53 | -0.33 | -0.21 | -1.27 |
Basic Weighted Average Shares Outstanding | 2M | 2M | 2M | 2.12M | 5.79M |
Net EPS - Diluted | 0.38 | 0.53 | -0.33 | -0.21 | -1.27 |
Diluted EPS - Continuing Operations | 0.38 | 0.53 | -0.33 | -0.21 | -1.27 |
Diluted Weighted Average Shares Outstanding | 2M | 2M | 2M | 2.12M | 5.79M |
Normalized Basic EPS | 0.27 | 0.39 | -0.24 | 0.04 | -0.75 |
Normalized Diluted EPS | 0.27 | 0.39 | -0.24 | 0.04 | -0.75 |
Supplemental Items | |||||
EBITDA | 914K | 1.3M | -614K | 10.36K | -4.56M |
EBITA | 881K | 1.22M | -697K | -76.56K | -4.61M |
EBIT | 881K | 1.22M | -697K | -76.56K | -4.61M |
EBITDAR | - | - | -422K | - | - |
Effective Tax Rate - (Ratio) | 11.9 | 26.58 | 8.92 | 392.22 | -5.78 |
Total Current Taxes | 195K | 305K | 96.45K | 441K | 403K |
Total Deferred Taxes | -93.3K | 80.52K | -160K | 148K | - |
Normalized Net Income | 533K | 787K | -489K | 93.96K | -4.35M |
Interest on Long-Term Debt | - | - | 102K | 85.92K | 39.43K |
Supplemental Operating Expense Items | |||||
Marketing Expenses | - | - | 5.73K | 25.21K | 1.78M |
Selling and Marketing Expenses | 928K | 812K | 596K | 435K | 1.44M |
General and Administrative Expenses | 625K | 1.05M | 1.18M | 3.51M | 6.28M |
Research And Development Expense From Footnotes | 103K | 628K | 588K | 302K | 585K |
Net Rental Expense, Total | - | - | 191K | - | - |
Imputed Operating Lease Interest Expense | - | - | 48.18K | - | - |
Imputed Operating Lease Depreciation | - | - | 143K | - | - |
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | 1.21M |
Total Stock-Based Compensation | - | - | - | - | 1.21M |
- Stock Market
- Stocks
- UZX Stock
- Financials LINKAGE
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















